About Biomeme
Biomeme is a company based in Philadelphia (United States) founded in 2013. Biomeme has raised $6.2 million across 7 funding rounds from investors including European Union, EIC Fund and Ben Franklin Technology Partners. Biomeme has completed 1 acquisition, including Predigen. Biomeme offers products and services including Franklin ISP, Franklin Your Platform, and Tests Pipeline. Biomeme operates in a competitive market with competitors including DermTech, Inflammatix, MeMed, GenMark Diagnostics and Sunbird Bio, among others.
- Headquarter Philadelphia, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.2 M (USD)
in 7 rounds
-
Latest Funding Round
$4.51 M (USD), Series A
May 01, 2017
-
Investors
European Union
& 3 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biomeme
Biomeme offers a comprehensive portfolio of products and services, including Franklin ISP, Franklin Your Platform, and Tests Pipeline.
Portable system for efficient molecular testing in remote areas.
Streamlines collaborative research with advanced diagnostics tools.
Facilitates rapid analysis for infectious disease detection.
People of Biomeme
Unlock access to complete
Funding Insights of Biomeme
Biomeme has successfully raised a total of $6.2M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $4.51 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biomeme
Biomeme has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, EIC Fund and Ben Franklin Technology Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Technology ecosystem growth is supported in Southeastern Pennsylvania.
|
Locked | Locked | Locked | |
|
Startup accelerator
|
Locked | Locked | Locked |
Investor details for Biomeme
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biomeme
Biomeme has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Predigen.
Investment portfolio details for Biomeme
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Gene expression signatures are developed for disease diagnostics.
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for Biomeme
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Biomeme
Detailed financials for Biomeme
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biomeme Comparisons
Peer comparison for Biomeme
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biomeme
Biomeme operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DermTech, Inflammatix, MeMed, GenMark Diagnostics and Sunbird Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| Locked | Locked | Locked |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
|
| Locked | Locked | Locked |
Miniaturized MRI platforms for clinical diagnostics are developed.
|
Detailed competitors of Biomeme
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biomeme
Complete news archive for Biomeme
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biomeme
Biomeme was founded in 2013.
Biomeme is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Biomeme is a funded company, having raised a total of $6.2M across 7 funding rounds to date.
Biomeme was founded in 2013 in Philadelphia, United States, within the biotechnology sector. A smartphone-based platform for DNA diagnostics is provided, enabling real-time qPCR through a docking station, sample preparation with targeted test kits, and result analysis via a mobile app. Operations focus on pathogen identification by DNA or RNA signatures, with initial applications directed toward sexually transmitted disease panels.
Biomeme's top competitors include Visby Medical, Inflammatix and DermTech.
Biomeme offers Franklin ISP, Franklin Your Platform, and Tests Pipeline.
Biomeme has made 1 acquisition, including Predigen.
Biomeme has 4 investors. Key investors include European Union, EIC Fund, Ben Franklin Technology Partners, and Dreamit.